# NIPT — Cell-Free DNA Screening

Source: https://www.pregnancypowerhour.com/tests/nipt-cell-free-dna
Last updated: 2026-07-01

> NIPT, or cell-free DNA screening, is an optional blood test available from 10 weeks of pregnancy that screens for certain chromosomal conditions and can determine fetal sex.

NIPT, or noninvasive prenatal testing, offers a way to screen for specific chromosomal conditions by analyzing fragments of placental DNA found in your blood, providing early insights without any physical risk to the pregnancy itself.

## What it is

NIPT, also known as cell-free DNA screening, is a blood test that looks at tiny pieces of placental DNA circulating in your bloodstream. These fragments of DNA are often identical to the baby's DNA and can provide clues about certain chromosomal conditions. It's a screening tool, which means it identifies a higher chance of a condition, but it doesn't give a definitive diagnosis. For example, evidence suggests NIPT has a detection rate of >99% for Down syndrome (trisomy 21).

It's important to understand that NIPT is not a diagnostic test. If a screening suggests a higher chance of a condition, further diagnostic testing, such as [CVS — Chorionic Villus Sampling](/tests/cvs-chorionic-villus-sampling) or amniocentesis, would be recommended to confirm the results before any decisions are made. While the false positive rate is low, it is a real consideration, particularly for rarer conditions like trisomy 13 and sex chromosome abnormalities.

Regarding who is offered NIPT, guidelines can vary. In the United States, the American College of Obstetricians and Gynecologists (ACOG) recommends offering NIPT to all pregnant people, regardless of age. In contrast, the UK's National Health Service (NHS) typically offers NIPT through its public system to individuals identified as higher risk, though private testing is widely available. You get to decide what feels right for you and your family.

Beyond screening for chromosomal conditions, NIPT can also accurately determine fetal sex from 10 weeks, making it the earliest accurate method available. Some NIPT panels may also include screening for microdeletions, such as DiGeorge syndrome, though these typically have lower detection rates and a higher chance of false positives.

## When and how it happens

This screening can typically be performed from 10 weeks of pregnancy, often between 10 and 14 weeks. It involves a simple blood draw, much like your [First Prenatal Blood Panel](/tests/first-prenatal-blood-panel). There's no special preparation needed, and because it's a blood test from your arm, it's considered noninvasive, meaning there's no direct risk to the pregnancy. Your provider might discuss this test during an early appointment, perhaps after your [Dating Ultrasound](/tests/dating-ultrasound) has confirmed your pregnancy's gestational age.

## What the results mean

If your NIPT results indicate a 'low risk,' it suggests a lower chance of the screened conditions. However, it's important to remember that a low-risk result does not guarantee a baby free of all conditions. If the results come back as 'high risk' or 'positive,' it means there's a higher chance of a chromosomal condition. This is not a diagnosis, and your provider will discuss the next steps, which typically involve offering a diagnostic test like [CVS — Chorionic Villus Sampling](/tests/cvs-chorionic-villus-sampling) or amniocentesis for confirmation. These diagnostic tests provide a definitive answer.

Understanding that false positives can occur, especially for rarer conditions, is part of making an informed decision about next steps. Your provider is your best resource for your specific situation and for interpreting your individual results.

## Questions worth asking

As you navigate your options, it can be helpful to have a few questions ready for your care provider. This helps you feel calm, clear, and confident in your choices. One option might be to ask:

*   What specific chromosomal conditions does this particular NIPT panel screen for, beyond Down syndrome?
*   How would a 'high-risk' result be communicated to me, and what are the immediate next steps and support options available?
*   What are the potential out-of-pocket costs for this test, and what does my insurance typically cover?
*   Given that this is a screening, what diagnostic options are available if a high-risk result comes back, and what are the risks and timelines associated with those?
*   How do the guidelines for offering NIPT differ between regions, like the ACOG recommendations versus the UK NHS approach, and how does that inform my choices?